Literature DB >> 1584571

Smoking and the risk of early metastases from uveal melanoma.

K M Egan1, E S Gragoudas, J M Seddon, S M Walsh.   

Abstract

Smoking is suspected of altering host immunity and may therefore hasten the development of metastases among cancer patients. The authors followed 946 patients with melanomas of the choroid and/or ciliary body who had been treated with proton beam irradiation and who had provided a smoking history during their evaluation before treatment. After a mean follow-up of 33 months, 98 patients were diagnosed with metastatic disease. Metastasis-free survival rates 3 years after irradiation were similar in association with never, past, and current cigarette smoking (86%, 89%, and 90%, respectively; P = 0.90). Rates also were similar with increasing pack-years of exposure and when the product smoked was cigarettes versus pipes or cigars only. Estimates for smoking effects were unchanged after adjusting for established prognostic factors for metastases. Results suggest that smoking does not alter the risk of metastases during the first few years after irradiation of choroidal melanomas.

Entities:  

Mesh:

Year:  1992        PMID: 1584571     DOI: 10.1016/s0161-6420(92)31936-0

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  3 in total

Review 1.  Risk factors for intraocular melanoma and occupational exposure.

Authors:  J M Lutz; I A Cree; A J Foss
Journal:  Br J Ophthalmol       Date:  1999-10       Impact factor: 4.638

Review 2.  The effectiveness and safety of proton radiation therapy for indications of the eye : a systematic review.

Authors:  Geertruida E Bekkering; Anne W S Rutjes; Vasiliy V Vlassov; Daniel M Aebersold; Konrade von Bremen; Peter Jüni; Jos Kleijnen
Journal:  Strahlenther Onkol       Date:  2009-04-16       Impact factor: 3.621

3.  Clinical features and survival outcomes of ocular melanoma in a multi-ethnic Asian cohort.

Authors:  Laura Ling Ying Tan; Jiancheng Hong; Wei Lin Goh; Esther Wei Yin Chang; Valerie Shiwen Yang; Eileen Poon; Nagavalli Somasundaram; Mohamad Farid; Anita Sook Yee Chan; Jason Yongsheng Chan
Journal:  Sci Rep       Date:  2020-10-01       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.